Showing 8741-8750 of 20877 results for "".
Achieving Success in IgAN & FSGS
https://reachmd.com/programs/cme/achieving-success-in-igan-fsgs/14677/Review underlying mechanisms of glomerulonephritis and sclerosis in patients with IgAN and FSGS and find out how emerging data may improve outcomes.When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
https://reachmd.com/programs/video-library/when-to-start-using-sglt2i-in-hfref-initiating-guideline-recommended-treatment-options/14734/This discussion is part of a series titled "When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options".IBD and Biosimilars: What Healthcare Professionals Need to Know
https://reachmd.com/programs/gi-insights/ibd-and-biosimilars-what-healthcare-professionals-need-to-know/13835/Do you know how the approval of biosimilars will impact the treatment of inflammatory bowel disease? Hear from our experts and stay up to date!Investigating Inflammatory Mediators in Chronic Rhinosinusitis
https://reachmd.com/programs/deep-breaths-updates-chest/investigating-inflammatory-mediators-chronic-rhinosinusitis/13423/Learn more about the role of inflammatory mediators in chronic rhinosinusitis.Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
https://reachmd.com/programs/cme/navigating-today-and-shaping-tomorrow-in-ism-personalized-strategies-with-current-and-emerging-kit-inhibitors/54388/Explore the latest clinical evidence on current and emerging KIT tyrosine kinase inhibitors in indolent systemic mastocytosis to optimize patient care.Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
https://reachmd.com/programs/cme/seeing-the-invisible-radiologic-precision-to-enable-early-intervention-in-bronchiectasis/56384/Join our experts in this engaging broadcast replay and improve your ability to differentiate the radiologic patterns of bronchiectasis from other lung diseases.Conference Coverage at ICCBH 2026: A New Frontier in Achondroplasia—Clinical Insights From the PROPEL 3 Trial of Oral Infigratinib in Children
https://reachmd.com/clinical-practice/endocrinology/conference-coverage-at-iccbh-2026-a-new-frontier-in-achondroplasiaclinical-insights-from-the-propel-3-trial-of-oral-infigratinib-in-children/57926/Explore the efficacy, safety, and clinical implications of the PROPEL 3 trial evaluating oral infigratinib in children with achondroplasia.Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
https://reachmd.com/programs/cme/talking-through-treatment-patientclinician-dialogue-on-perioperative-immunotherapy-in-locally-advanced-hnscc/56431/Explore perioperative immunotherapy in locally advanced HNSCC through patient–clinician dialogue, clinical evidence, and multidisciplinary care.Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
https://reachmd.com/programs/cme/Beyond-Cognition-Managing-Alzheimers-as-an-Integrated-Neurodegenerative-Neuropsychiatric-Syndrome/54842/Examine integrated neurodegenerative and neuropsychiatric features of Alzheimer’s disease, including NPS biology and therapeutic strategies.Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
https://reachmd.com/programs/cme/clinical-criteria-and-imaging-strategies-for-b7-h3directed-adcs-in-es-sclc/39977/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.